nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—MAPK1—multiple sclerosis	0.506	1	CbGaD
Arsenic trioxide—CYP1B1—Mitoxantrone—multiple sclerosis	0.0667	0.242	CbGbCtD
Arsenic trioxide—CYP1B1—Dexamethasone—multiple sclerosis	0.0346	0.125	CbGbCtD
Arsenic trioxide—ABCC2—Dexamethasone—multiple sclerosis	0.0182	0.0659	CbGbCtD
Arsenic trioxide—ABCB1—Methylprednisolone—multiple sclerosis	0.0157	0.0568	CbGbCtD
Arsenic trioxide—CYP1A1—Dexamethasone—multiple sclerosis	0.0152	0.055	CbGbCtD
Arsenic trioxide—ABCC2—Methotrexate—multiple sclerosis	0.0146	0.0529	CbGbCtD
Arsenic trioxide—CYP3A4—Fingolimod—multiple sclerosis	0.0146	0.0528	CbGbCtD
Arsenic trioxide—ABCB1—Mitoxantrone—multiple sclerosis	0.0114	0.0414	CbGbCtD
Arsenic trioxide—ABCB1—Betamethasone—multiple sclerosis	0.0102	0.0369	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—multiple sclerosis	0.0101	0.0364	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—multiple sclerosis	0.00949	0.0344	CbGbCtD
Arsenic trioxide—CYP3A4—Methylprednisolone—multiple sclerosis	0.00939	0.034	CbGbCtD
Arsenic trioxide—CYP3A4—Triamcinolone—multiple sclerosis	0.00711	0.0258	CbGbCtD
Arsenic trioxide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00685	0.0248	CbGbCtD
Arsenic trioxide—CYP3A4—Betamethasone—multiple sclerosis	0.0061	0.0221	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisolone—multiple sclerosis	0.00602	0.0218	CbGbCtD
Arsenic trioxide—ABCB1—Dexamethasone—multiple sclerosis	0.00593	0.0215	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—multiple sclerosis	0.00569	0.0206	CbGbCtD
Arsenic trioxide—AKT1—leg—multiple sclerosis	0.00503	0.0895	CbGeAlD
Arsenic trioxide—ABCB1—Methotrexate—multiple sclerosis	0.00476	0.0173	CbGbCtD
Arsenic trioxide—CYP3A4—Dexamethasone—multiple sclerosis	0.00355	0.0129	CbGbCtD
Arsenic trioxide—JUN—peripheral nervous system—multiple sclerosis	0.00305	0.0542	CbGeAlD
Arsenic trioxide—AKT1—nerve—multiple sclerosis	0.00273	0.0486	CbGeAlD
Arsenic trioxide—JUN—nerve—multiple sclerosis	0.00238	0.0423	CbGeAlD
Arsenic trioxide—CCND1—retina—multiple sclerosis	0.00161	0.0286	CbGeAlD
Arsenic trioxide—MAPK1—brainstem—multiple sclerosis	0.00141	0.025	CbGeAlD
Arsenic trioxide—TXNRD1—retina—multiple sclerosis	0.00126	0.0224	CbGeAlD
Arsenic trioxide—MAPK3—retina—multiple sclerosis	0.0012	0.0213	CbGeAlD
Arsenic trioxide—AKT1—brainstem—multiple sclerosis	0.00117	0.0209	CbGeAlD
Arsenic trioxide—CCND1—medulla oblongata—multiple sclerosis	0.00116	0.0207	CbGeAlD
Arsenic trioxide—AKT1—retina—multiple sclerosis	0.00113	0.0201	CbGeAlD
Arsenic trioxide—CCND1—midbrain—multiple sclerosis	0.00106	0.0189	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—multiple sclerosis	0.00104	0.0184	CbGeAlD
Arsenic trioxide—JUN—brainstem—multiple sclerosis	0.00102	0.0182	CbGeAlD
Arsenic trioxide—JUN—retina—multiple sclerosis	0.000985	0.0175	CbGeAlD
Arsenic trioxide—TXNRD1—medulla oblongata—multiple sclerosis	0.000913	0.0162	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—multiple sclerosis	0.000874	0.0155	CbGeAlD
Arsenic trioxide—CCND1—nervous system—multiple sclerosis	0.000874	0.0155	CbGeAlD
Arsenic trioxide—MAPK3—medulla oblongata—multiple sclerosis	0.000868	0.0154	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—multiple sclerosis	0.000842	0.015	CbGeAlD
Arsenic trioxide—TXNRD1—midbrain—multiple sclerosis	0.000834	0.0148	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—multiple sclerosis	0.000823	0.0146	CbGeAlD
Arsenic trioxide—AKT1—medulla oblongata—multiple sclerosis	0.000818	0.0145	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—multiple sclerosis	0.000814	0.0145	CbGeAlD
Arsenic trioxide—MAPK3—midbrain—multiple sclerosis	0.000793	0.0141	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—multiple sclerosis	0.000774	0.0138	CbGeAlD
Arsenic trioxide—AKT1—midbrain—multiple sclerosis	0.000748	0.0133	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—multiple sclerosis	0.000737	0.0131	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—multiple sclerosis	0.00073	0.013	CbGeAlD
Arsenic trioxide—JUN—medulla oblongata—multiple sclerosis	0.000712	0.0127	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—multiple sclerosis	0.000709	0.0126	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—multiple sclerosis	0.000693	0.0123	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—multiple sclerosis	0.000686	0.0122	CbGeAlD
Arsenic trioxide—CCND1—brain—multiple sclerosis	0.000668	0.0119	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—multiple sclerosis	0.00066	0.0117	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—multiple sclerosis	0.000652	0.0116	CbGeAlD
Arsenic trioxide—JUN—midbrain—multiple sclerosis	0.000651	0.0116	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—multiple sclerosis	0.000645	0.0115	CbGeAlD
Arsenic trioxide—JUN—spinal cord—multiple sclerosis	0.000635	0.0113	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—multiple sclerosis	0.000628	0.0112	CbGeAlD
Arsenic trioxide—AKT1—nervous system—multiple sclerosis	0.000615	0.0109	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—multiple sclerosis	0.000614	0.0109	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—multiple sclerosis	0.000592	0.0105	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—multiple sclerosis	0.000579	0.0103	CbGeAlD
Arsenic trioxide—MAPK1—brain—multiple sclerosis	0.000563	0.01	CbGeAlD
Arsenic trioxide—JUN—nervous system—multiple sclerosis	0.000535	0.00951	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—multiple sclerosis	0.000533	0.00947	CbGeAlD
Arsenic trioxide—TXNRD1—brain—multiple sclerosis	0.000524	0.00932	CbGeAlD
Arsenic trioxide—JUN—central nervous system—multiple sclerosis	0.000515	0.00916	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—multiple sclerosis	0.000513	0.00911	CbGeAlD
Arsenic trioxide—JUN—cerebellum—multiple sclerosis	0.000504	0.00895	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—multiple sclerosis	0.000501	0.00891	CbGeAlD
Arsenic trioxide—MAPK3—brain—multiple sclerosis	0.000498	0.00886	CbGeAlD
Arsenic trioxide—AKT1—brain—multiple sclerosis	0.00047	0.00835	CbGeAlD
Arsenic trioxide—JUN—brain—multiple sclerosis	0.000409	0.00727	CbGeAlD
Arsenic trioxide—IKBKB—brain—multiple sclerosis	0.000407	0.00724	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—multiple sclerosis	0.000285	0.00507	CbGeAlD
Arsenic trioxide—CCND1—Azacitidine—Cladribine—multiple sclerosis	0.000279	0.0843	CbGdCrCtD
Arsenic trioxide—CYP1B1—central nervous system—multiple sclerosis	0.000275	0.00488	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—multiple sclerosis	0.000268	0.00477	CbGeAlD
Arsenic trioxide—CYP1B1—brain—multiple sclerosis	0.000218	0.00388	CbGeAlD
Arsenic trioxide—AKT1—Azacitidine—Cladribine—multiple sclerosis	0.000211	0.0639	CbGdCrCtD
Arsenic trioxide—CYP1A1—nervous system—multiple sclerosis	0.000202	0.00358	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—multiple sclerosis	0.000194	0.00345	CbGeAlD
Arsenic trioxide—ABCB1—retina—multiple sclerosis	0.000193	0.00343	CbGeAlD
Arsenic trioxide—CYP1A1—brain—multiple sclerosis	0.000154	0.00274	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—multiple sclerosis	0.000148	0.00263	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—multiple sclerosis	0.000142	0.00253	CbGeAlD
Arsenic trioxide—ABCB1—medulla oblongata—multiple sclerosis	0.000139	0.00248	CbGeAlD
Arsenic trioxide—ABCB1—midbrain—multiple sclerosis	0.000127	0.00226	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—multiple sclerosis	0.000124	0.00221	CbGeAlD
Arsenic trioxide—TXNRD1—Flunisolide—Methylprednisolone—multiple sclerosis	0.000116	0.0349	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Methylprednisolone—multiple sclerosis	0.000114	0.0345	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000114	0.0345	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Betamethasone—multiple sclerosis	0.000114	0.0344	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Dexamethasone—multiple sclerosis	0.000114	0.0344	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Betamethasone—multiple sclerosis	0.000112	0.0339	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Dexamethasone—multiple sclerosis	0.000112	0.0339	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000112	0.0337	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Triamcinolone—multiple sclerosis	0.000111	0.0336	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00011	0.0332	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00011	0.0332	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Triamcinolone—multiple sclerosis	0.00011	0.0331	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Triamcinolone—multiple sclerosis	0.00011	0.0331	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000107	0.0324	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—multiple sclerosis	0.000105	0.0319	CbGdCrCtD
Arsenic trioxide—ABCB1—nervous system—multiple sclerosis	0.000105	0.00186	CbGeAlD
Arsenic trioxide—JUN—Betamethasone—Prednisone—multiple sclerosis	0.000104	0.0315	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—multiple sclerosis	0.000104	0.0315	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—multiple sclerosis	0.000103	0.0311	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—multiple sclerosis	0.000102	0.0307	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—multiple sclerosis	0.000102	0.0307	CbGdCrCtD
Arsenic trioxide—ABCB1—central nervous system—multiple sclerosis	0.000101	0.00179	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—multiple sclerosis	9.86e-05	0.00175	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—multiple sclerosis	9.72e-05	0.0294	CbGdCrCtD
Arsenic trioxide—ABCB1—brain—multiple sclerosis	8.01e-05	0.00142	CbGeAlD
Arsenic trioxide—TXNRD1—Dexamethasone—Methylprednisolone—multiple sclerosis	5.65e-05	0.0171	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Methylprednisolone—multiple sclerosis	5.65e-05	0.0171	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Dexamethasone—multiple sclerosis	5.56e-05	0.0168	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Betamethasone—multiple sclerosis	5.56e-05	0.0168	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Triamcinolone—multiple sclerosis	5.44e-05	0.0164	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Triamcinolone—multiple sclerosis	5.44e-05	0.0164	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—multiple sclerosis	5.16e-05	0.0156	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—multiple sclerosis	5.16e-05	0.0156	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—multiple sclerosis	5.04e-05	0.0152	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—multiple sclerosis	5.04e-05	0.0152	CbGdCrCtD
Arsenic trioxide—MAPK1—Disease—CCR5—multiple sclerosis	5.12e-06	3.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TGFB1—multiple sclerosis	5.11e-06	3.22e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—MAPK1—multiple sclerosis	5.07e-06	3.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—APOE—multiple sclerosis	5.05e-06	3.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.05e-06	3.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CCL2—multiple sclerosis	5.03e-06	3.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL10—multiple sclerosis	5.01e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TGFB1—multiple sclerosis	5.01e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MAPK1—multiple sclerosis	5.01e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—RRM1—multiple sclerosis	5.01e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HLA-A—multiple sclerosis	4.99e-06	3.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—POMC—multiple sclerosis	4.99e-06	3.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ICAM1—multiple sclerosis	4.98e-06	3.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TLR4—multiple sclerosis	4.95e-06	3.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD80—multiple sclerosis	4.95e-06	3.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DRB1—multiple sclerosis	4.94e-06	3.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—multiple sclerosis	4.92e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CNR1—multiple sclerosis	4.92e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—MAPK1—multiple sclerosis	4.92e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APOE—multiple sclerosis	4.9e-06	3.09e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2—multiple sclerosis	4.89e-06	3.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CCL2—multiple sclerosis	4.88e-06	3.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL10—multiple sclerosis	4.86e-06	3.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.86e-06	3.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TGFB1—multiple sclerosis	4.86e-06	3.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD80—multiple sclerosis	4.8e-06	3.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—multiple sclerosis	4.77e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TGFB1—multiple sclerosis	4.77e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MAPK1—multiple sclerosis	4.75e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—POMC—multiple sclerosis	4.75e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—MYC—multiple sclerosis	4.74e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ICAM1—multiple sclerosis	4.74e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TLR4—multiple sclerosis	4.73e-06	2.98e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DRB1—multiple sclerosis	4.73e-06	2.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APOE—multiple sclerosis	4.66e-06	2.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CCL2—multiple sclerosis	4.65e-06	2.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—MAPK1—multiple sclerosis	4.64e-06	2.93e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP9—multiple sclerosis	4.63e-06	2.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL10—multiple sclerosis	4.63e-06	2.92e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.62e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.61e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—TYK2—multiple sclerosis	4.57e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD80—multiple sclerosis	4.57e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD80—multiple sclerosis	4.57e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MAPK1—multiple sclerosis	4.56e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CD86—multiple sclerosis	4.56e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—multiple sclerosis	4.54e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ICAM1—multiple sclerosis	4.54e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.52e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—MYC—multiple sclerosis	4.51e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL5—multiple sclerosis	4.49e-06	2.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—TYK2—multiple sclerosis	4.43e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD80—multiple sclerosis	4.43e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL10—multiple sclerosis	4.43e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MAPK1—multiple sclerosis	4.43e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CD86—multiple sclerosis	4.38e-06	2.76e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD80—multiple sclerosis	4.37e-06	2.75e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TYK2—multiple sclerosis	4.35e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL5—multiple sclerosis	4.32e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.3e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CD86—multiple sclerosis	4.25e-06	2.68e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—APOE—multiple sclerosis	4.23e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—TYK2—multiple sclerosis	4.22e-06	2.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD80—multiple sclerosis	4.22e-06	2.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—multiple sclerosis	4.19e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL5—multiple sclerosis	4.19e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.18e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TYK2—multiple sclerosis	4.18e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SPP1—multiple sclerosis	4.16e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—STAT3—multiple sclerosis	4.12e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNG—multiple sclerosis	4.07e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.07e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.07e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TYK2—multiple sclerosis	4.05e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR5—multiple sclerosis	4.05e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CD86—multiple sclerosis	4.05e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MAPK1—multiple sclerosis	4.03e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SPP1—multiple sclerosis	4e-06	2.52e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2RA—multiple sclerosis	3.99e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL5—multiple sclerosis	3.98e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—multiple sclerosis	3.97e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—multiple sclerosis	3.93e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNG—multiple sclerosis	3.91e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR5—multiple sclerosis	3.89e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SPP1—multiple sclerosis	3.88e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CD86—multiple sclerosis	3.87e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TYK2—multiple sclerosis	3.86e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TYK2—multiple sclerosis	3.85e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—multiple sclerosis	3.85e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2RA—multiple sclerosis	3.83e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MYC—multiple sclerosis	3.83e-06	2.41e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TGFB1—multiple sclerosis	3.82e-06	2.41e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL5—multiple sclerosis	3.81e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.81e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—multiple sclerosis	3.8e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNG—multiple sclerosis	3.79e-06	2.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—multiple sclerosis	3.78e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—multiple sclerosis	3.77e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MAPK1—multiple sclerosis	3.74e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TYK2—multiple sclerosis	3.74e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.72e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2RA—multiple sclerosis	3.72e-06	2.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SPP1—multiple sclerosis	3.69e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—multiple sclerosis	3.69e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TYK2—multiple sclerosis	3.69e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOE—multiple sclerosis	3.68e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—multiple sclerosis	3.66e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—multiple sclerosis	3.66e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—multiple sclerosis	3.65e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—POMC—multiple sclerosis	3.63e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—multiple sclerosis	3.63e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—multiple sclerosis	3.62e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNG—multiple sclerosis	3.61e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.6e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—multiple sclerosis	3.59e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TYK2—multiple sclerosis	3.56e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOE—multiple sclerosis	3.54e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2RA—multiple sclerosis	3.54e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SPP1—multiple sclerosis	3.53e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOE—multiple sclerosis	3.52e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—multiple sclerosis	3.51e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—multiple sclerosis	3.51e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—multiple sclerosis	3.49e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—multiple sclerosis	3.49e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—multiple sclerosis	3.49e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—multiple sclerosis	3.48e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNG—multiple sclerosis	3.45e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—multiple sclerosis	3.43e-06	2.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOE—multiple sclerosis	3.43e-06	2.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—multiple sclerosis	3.4e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2RA—multiple sclerosis	3.38e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—multiple sclerosis	3.38e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—multiple sclerosis	3.38e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—multiple sclerosis	3.37e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—multiple sclerosis	3.33e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CD80—multiple sclerosis	3.33e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ALB—multiple sclerosis	3.31e-06	2.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOE—multiple sclerosis	3.26e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—multiple sclerosis	3.24e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—multiple sclerosis	3.22e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—multiple sclerosis	3.22e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—multiple sclerosis	3.21e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CD80—multiple sclerosis	3.2e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—POMC—multiple sclerosis	3.16e-06	1.99e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOE—multiple sclerosis	3.12e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CD80—multiple sclerosis	3.1e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—multiple sclerosis	3.1e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL2—multiple sclerosis	3.1e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.08e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—multiple sclerosis	3.08e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—multiple sclerosis	3.07e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—STAT3—multiple sclerosis	3.04e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—POMC—multiple sclerosis	3.04e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—POMC—multiple sclerosis	3.02e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL2—multiple sclerosis	2.97e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CD80—multiple sclerosis	2.95e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—POMC—multiple sclerosis	2.95e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—STAT3—multiple sclerosis	2.92e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—MAPK1—multiple sclerosis	2.91e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.89e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL2—multiple sclerosis	2.88e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—multiple sclerosis	2.88e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—BCHE—multiple sclerosis	2.88e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—STAT3—multiple sclerosis	2.84e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CD80—multiple sclerosis	2.82e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—MAPK1—multiple sclerosis	2.82e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TYK2—multiple sclerosis	2.81e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—POMC—multiple sclerosis	2.8e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MAPK1—multiple sclerosis	2.77e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—multiple sclerosis	2.75e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL2—multiple sclerosis	2.74e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—MYC—multiple sclerosis	2.7e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TYK2—multiple sclerosis	2.7e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—STAT3—multiple sclerosis	2.7e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—STAT3—multiple sclerosis	2.7e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—POMC—multiple sclerosis	2.68e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MAPK1—multiple sclerosis	2.66e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL2—multiple sclerosis	2.63e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—MYC—multiple sclerosis	2.62e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TYK2—multiple sclerosis	2.62e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—STAT3—multiple sclerosis	2.62e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—STAT3—multiple sclerosis	2.58e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MAPK1—multiple sclerosis	2.58e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MYC—multiple sclerosis	2.51e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—multiple sclerosis	2.5e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TYK2—multiple sclerosis	2.49e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STAT3—multiple sclerosis	2.49e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MAPK1—multiple sclerosis	2.45e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MYC—multiple sclerosis	2.43e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—multiple sclerosis	2.43e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TYK2—multiple sclerosis	2.38e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MAPK1—multiple sclerosis	2.38e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MAPK1—multiple sclerosis	2.35e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—multiple sclerosis	2.34e-06	1.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MYC—multiple sclerosis	2.32e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—multiple sclerosis	2.31e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—multiple sclerosis	2.25e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—multiple sclerosis	2.24e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—multiple sclerosis	2.21e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—multiple sclerosis	2.18e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—multiple sclerosis	2.17e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—multiple sclerosis	2.17e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—multiple sclerosis	2.13e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—multiple sclerosis	2.13e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—multiple sclerosis	2.07e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—multiple sclerosis	2.06e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—multiple sclerosis	2.06e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—multiple sclerosis	2.04e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—multiple sclerosis	1.98e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—multiple sclerosis	1.98e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—multiple sclerosis	1.97e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—multiple sclerosis	1.96e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—multiple sclerosis	1.89e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—multiple sclerosis	1.89e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—multiple sclerosis	1.89e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—multiple sclerosis	1.88e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—POMC—multiple sclerosis	1.86e-06	1.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—multiple sclerosis	1.83e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—multiple sclerosis	1.83e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MYC—multiple sclerosis	1.83e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—multiple sclerosis	1.82e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—multiple sclerosis	1.8e-06	1.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK1—multiple sclerosis	1.79e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.77e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MYC—multiple sclerosis	1.76e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—multiple sclerosis	1.75e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—multiple sclerosis	1.74e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—multiple sclerosis	1.74e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—multiple sclerosis	1.73e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK1—multiple sclerosis	1.72e-06	1.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MYC—multiple sclerosis	1.7e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—multiple sclerosis	1.7e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—multiple sclerosis	1.7e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—multiple sclerosis	1.67e-06	1.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MAPK1—multiple sclerosis	1.67e-06	1.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MYC—multiple sclerosis	1.62e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—multiple sclerosis	1.62e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MYC—multiple sclerosis	1.55e-06	9.78e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-06	9.76e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-06	9.57e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—POMC—multiple sclerosis	1.49e-06	9.37e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—multiple sclerosis	1.37e-06	8.67e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—multiple sclerosis	1.35e-06	8.54e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—multiple sclerosis	1.32e-06	8.33e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—multiple sclerosis	1.28e-06	8.08e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—multiple sclerosis	1.22e-06	7.68e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—multiple sclerosis	1.17e-06	7.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—multiple sclerosis	1.07e-06	6.72e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—POMC—multiple sclerosis	9.16e-07	5.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—multiple sclerosis	8.35e-07	5.26e-06	CbGpPWpGaD
